{"name":"Lawrence Fong","slug":"lawrence-fong","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPLTkwVW1pVWtMdU9heEs4eUhHUm9xU2ljNUo4MGtLUlJJN2FzbDV2b1lDT0RjMXFtb0pnZTVuZTFqWWtEMXZZdlMyNDJsaklTYmhVLV81cnlhSnI2UDVkTHEyQ1pKYWdJYzgxZ1Rab2p1dEEzaDBBWi1NV2c5bTh0aWc2RU9faUg5T0xheG9VeXRZQWQ1UURCVmVIVk9YMG1zU1JmLUlCMjlCaHlPc3FSTGlYU0R6VklOZGRqTmNIakZEZF9GdDBZcXYxcVpudnpFcF8zYUdjd1pxWXczMXR0T3NPd20xblRhM0VSMXQ0YzI3Zw?oc=5","date":"2024-08-15","type":"pipeline","source":"fredhutch.org","summary":"Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology - fredhutch.org","headline":"Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNTjBZMmp2bVJxMWFOM1hBWmZoeWl4MmktT0xmVmZPUERKVGFjeVlJSm9RZWRScGZINTlQX09NODBVSU5OSFVCV2stcDdpMVkydDByR2ZhQW1aYnY0SVBxb1UyRnpqTnkwTHdUUll0MGh1N2R5YlJTbGNEZDhwOWppY1Nlbw?oc=5","date":"2023-10-12","type":"pipeline","source":"fredhutch.org","summary":"Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center - fredhutch.org","headline":"Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9JSjNhUWZicnVSV0JtRjhrY19ZbWFwYXBFT3NtYWwwM215VUVBVUlacVdGM0dOUWxXMEd4X29CX3lEd1NYdUg2anBiSm9Qck02V3g3d0hmaU1kNWpjX3hOQw?oc=5","date":"2017-02-17","type":"pipeline","source":"NEJM","summary":"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma - NEJM","headline":"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}